Apparatus and methods for biosynthetic production of cannabinoids
The present invention provides an apparatus and methods for producing tetrahydrocannabinolic acid (THCA), cannabichromenic acid (CBCA) and cannabichromenic acid (CBCA) in different ratios. The apparatus comprises: (i) a bioreactor comprising (a) an automated supply system configured to deliver a first automated supply of cannabigerolic acid (CBGA), a cannabinoid acid synthase, and a reaction mixture; and (b) a second automated system to cease the reaction; (ii) a controller configured to modify a property of the reaction mixture to produce the desired products; and (iii) an extractor configured to recover the tetrahydrocannabinolic acid (THCA), cannabichromenic acid (CBCA) or cannabidiolic acid (CBDA) and cannabichromenic acid.
1. A system for producing cannabinoids wherein the system comprises:
(i) a bioreactor comprising cells stably transformed with one or more cannabinoid genes;
(ii) a reaction mixture comprising a compound according to Formula I:
wherein
R is selected from —OH, halogen, —SH, or a —NR a R b group;
R 1 and R 2 are each independently selected from the group consisting of —H, —C(O)R a , —OR a , an optionally substituted C 1 -C 10 linear or branched alkylene, an optionally substituted C 2 -C 10 linear or branched alkenylene, an optionally substituted C 2 -C 10 linear or branched alkynylene, an optionally substituted C 3 -C 10 aryl, an optionally substituted C 3 -C 10 cycloalkyl, (C 3 -C 10 )aryl-(C 1 -C 10 )alkylene, (C 3 -C 10 )aryl-(C 2 -C 10 )alkenylene, and (C 3 -C 10 )aryl-(C 1 -C 10 )alkynylene, or R 1 and R 2 together with the carbon atoms to which they are bonded form a C 5 -C 10 cyclic ring;
R 3 is selected from the group consisting of H, —C(O)R a and C 1 -C 10 linear or branched alkyl; and
R a and R b are each independently —H, —OH, —SH, —NH 2 , (C 1 -C 10 ) linear or branched alkyl, or a C 3 -C 10 cycloalkyl; and
(iii) a controller configured to modify one or more reaction conditions to modulate the ratio of the cannabinoid products, wherein the condition to be modified is pH or solvent.
2. The system of claim 1 , wherein the cells are selected from the group consisting of fungal, animal, algal, and bacterial.
3. The system of claim 2 , wherein the fungal cells are yeast cells.
4. The system of claim 1 , wherein the cannabinoid biosynthetic gene is the tetrahydrocannabinolic acid (THCA) synthase gene.
5. The system of claim 1 , wherein the cannabinoid biosynthetic gene is the cannabidiolic acid (CBDA) synthase gene.
6. The system of claim 1 , wherein cannabigerolic acid (CBGA) is a reagent in the reaction mixture.
7. The system of claim 1 , wherein R is —OH and R 1 is —H or —COOH.
8. The system of claim 1 , wherein R 2 is a C 1 -C 10 linear or branched alkyl wherein said C 1 -C 10 linear or branched alkyl is selected from the group consisting of CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 5 H 11 , C 6 H 13 , C 7 H 15 , C 8 H 17 , iso-propyl, sec-butyl, iso-butyl, neopentyl, 2-methyl hexyl, and 2,3-dimethyl hexyl.
9. The system of claim 1 , wherein R 2 is selected from the group consisting of CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 6 H 13 , C 7 H 15 and C 8 H 17 .
10. The system of claim 1 , wherein R 2 is C 3 H 7 .
11. The system of claim 1 , wherein R 2 is C 5 H 10 .
12. The system of claim 1 , wherein;
R is —OH
R 1 is —H or —COOH;
R 2 is a C 1 -C 10 linear or branched alkyl wherein said C 1 -C 10 linear or branched alkyl is selected from the group consisting of CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 6 H 13 , C 7 H 15 , C 8 H 17 , iso-propyl, sec-butyl, iso-butyl, neopentyl, 2-methyl hexyl, and 2,3-dimethyl hexyl;
R 3 is H.